Source: Annual Congress 2002 - Tuberculosis management -2
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. S. Avdeev, P. S. Krivonos, V. N. Shamshur, A. A. Novic, A. F. Grinevich (Minsk, Belarus). Differentiated approaches for chemoprophylaxis of tuberculosis in prisons. Eur Respir J 2002; 20: Suppl. 38, 3393

Member's Comments

No comment yet.

Related content which might interest you: Experience of isofon use for therapy and chemoprophylaxis of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 486s Year: 2004 New approaches to treatment of HIV-associated tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 Peculiarities of tuberculosis case-finding in migrants Source: Eur Respir J 2004; 24: Suppl. 48, 420s Year: 2004 HIV-associated tuberculosis in prisons Source: Eur Respir J 2004; 24: Suppl. 48, 196s Year: 2004 Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Stabilization measures of tuberculosis epidemic situation in prisons Source: Eur Respir J 2002; 20: Suppl. 38, 164s Year: 2002 Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 Active case-finding of tuberculosis in Europe Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis Year: 2007 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Treatment of latent tuberculosis in immigrants from Somalia: Case-monitoring and adherence Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Medico-surgical considerations when looking for treatment for multidrug-resistant TB Source: Eur Respir J 2002; 20: Suppl. 38, 361s Year: 2002 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration Source: Eur Respir J 2016; 47: 686-688 Year: 2016 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007 Bedaquiline-containing regimens for MDR TB treatment – Focus on the safety Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016